Faculty/Staff Highlight

Biomarkers, Stem Cells Offer New Ways to Treat Deadly Gut Disease in Premature Babies

After nearly two decades of work, two major breakthroughs by CCTS supported researchers Gail Bresner, MD (pictured) and R. Lawrence Moss, MD, have yielded both the discovery of a biomarker that can help predict which babies will get necrotizing enterocolitis, as well as treatments that can restore the intestine’s natural ability to protect itself against the disease.

Recent Citations

Authors N. Dewall; T. Deckman; M.T. Gailliot; B.J. Bushman
Authors S.R. Jadcherla; J. Peng; R. Moore; J. Saavedra; E. Shepherd; S. Fernandez; S.H. Erdman; C. DiLorenzo
Authors S.R. Jadcherla; V.N. Parks; J. Peng; S. Dzodzomenyo; S. Fernandez; R. Shaker; M. Splaingard